Novel potent anti-STEAP1 bispecific antibody to redirect T cells for cancer immunotherapy
Guardado en:
Autores principales: | Hong-fen Guo, Nai-Kong V Cheung, Jeong A Park, Alan Long, Tsung-Yi Lin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1417a766f63b4510809ccc4f8117efda |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficient and Highly Specific Gene Transfer Using Mutated Lentiviral Vectors Redirected with Bispecific Antibodies
por: Christina L. Parker, et al.
Publicado: (2020) -
Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning
por: Lauric Haber, et al.
Publicado: (2021) -
Bispecific binder redirected lentiviral vector enables in vivo engineering of CAR-T cells
por: Barbara Savoldo, et al.
Publicado: (2021) -
Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity
por: Congcong Zhang, et al.
Publicado: (2021) -
A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities
por: Xiaopei Cui, et al.
Publicado: (2021)